Tetsuya Taguchi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Living Beings

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Toi M; Iwata H; Fujiwara Y; Ito Y; Nakamura S; Tokuda Y; Taguchi T; Rai Y; Aogi K; Arai T; Watanabe J; Wakamatsu T; Katsura K; Ellis C E; Gagnon R C; Allen K E; Sasaki Y; Takashima S
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.
Taguchi Tetsuya; Noguchi Shinzaburo
[Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer]
Tanei Tomonori; Morimoto Koji; Shimazu Kenzo; Kim Seung Jin; Tanji Yoshio; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Tetsuya Taguchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Toi M; Iwata H; Fujiwara Y; Ito Y; Nakamura S; Tokuda Y; Taguchi T; Rai Y; Aogi K; Arai T; Watanabe J; Wakamatsu T; Katsura K; Ellis C E; Gagnon R C; Allen K E; Sasaki Y; Takashima S
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.
British journal of cancer 2009;101(10):1676-82.
2009: Taguchi Tetsuya; Noguchi Shinzaburo
[Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 2009;36(9):1465-74.
2009: Tanei Tomonori; Morimoto Koji; Shimazu Kenzo; Kim Seung Jin; Tanji Yoshio; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4234-41.
2009: Morimoto Koji; Kim Seung Jin; Tanei Tomonori; Shimazu Kenzo; Tanji Yoshio; Taguchi Tetsuya; Tamaki Yasuhiro; Terada Nobuyuki; Noguchi Shinzaburo
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Cancer science 2009;100(6):1062-8.
2009: Okishiro Masatsugu; Taguchi Tetsuya; Kim Seung Jin; Tanji Yoshio; Shimazu Kenzo; Tamaki Yasuhiro; Noguchi Shinzaburo
Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
Journal of cancer research and clinical oncology 2009;135(6):823-7.
2009: Okishiro Masatsugu; Taguchi Tetsuya; Jin Kim Seung; Shimazu Kenzo; Tamaki Yasuhiro; Noguchi Shinzaburo
Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.
Cancer 2009;115(5):952-61.
2009: Shimomura Atsushi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of loss of BRCA1 expression with centrosome aberration in human breast cancer.
Journal of cancer research and clinical oncology 2009;135(3):421-30.
2009: Kim Seung Jin; Taguchi Tetsuya; Shimazu Kenzo; Tanji Yoshio; Tamaki Yasuhiro; Noguchi Shinzaburo
Good response to paclitaxel predicts high rates of pathologic complete response for breast cancer patients treated preoperatively with paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide.
Oncology 2009;77(2):134-9.
2008: Akazawa Kenji; Tamaki Yasuhiro; Taguchi Tetsuya; Tanji Yoshio; Miyoshi Yasuo; Kim Seung Jim; Shimazu Kenzo; Ueda Satsuki; Yanagisawa Tetsu; Okishiro Noritsugu; Imazato Mitsunobu; Yasuyuki Kozuma; Sato Yoshinobu; Tamura Shinichi; Noguchi Shinzaburo
Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy.
The breast journal 2008;14(6):523-31.
2008: Miyoshi Yasuo; Kurosumi Masafumi; Kurebayashi Junichi; Matsuura Nariaki; Takahashi Masato; Tokunaga Eriko; Egawa Chiyomi; Masuda Norikazu; Kim Seung Jin; Okishiro Masatsugu; Yanagisawa Tetsu; Ueda Satsuki; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo;
Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.
Cancer letters 2008;264(1):44-53.
2008: Shimazu Kenzo; Tamaki Yasuhiro; Taguchi Tetsuya; Tsukamoto Fumine; Kasugai Tsutomu; Noguchi Shinzaburo
Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy.
Annals of surgical oncology 2008;15(6):1717-22.
2008: Miyoshi Yasuo; Kurosumi Masafumi; Kurebayashi Junichi; Matsuura Nariaki; Takahashi Masato; Tokunaga Eriko; Egawa Chiyomi; Masuda Norikazu; Kim Seung Jin; Okishiro Masatsugu; Yanagisawa Tetsu; Ueda Satsuki; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo;
Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.
Journal of cancer research and clinical oncology 2008;134(5):561-7.
2008: Naoi Yasuto; Miyoshi Yasuo; Taguchi Tetsuya; Kim Seung Jin; Arai Takashi; Maruyama Naomi; Tamaki Yasuhiro; Noguchi Shinzaburo
Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers.
Cancer letters 2008;262(2):248-56.
2008: Ueda Satsuki; Tamaki Yasuhiro; Yano Kenji; Okishiro Noritsugu; Yanagisawa Tetsu; Imasato Mitsunobu; Shimazu Kenzo; Kim Seun J; Miyoshi Yasuo; Tanji Yoshio; Taguchi Tetsuya; Noguchi Shinzaburo
Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast.
Surgery 2008;143(3):414-25.
2008: Kotsuma Yasuyuki; Tamaki Yasuhiro; Nishimura Toshihiro; Tsubai Masayoshi; Ueda Satsuki; Shimazu Kenzo; Jin Kim Seung; Miyoshi Yasuo; Tanji Yoshio; Taguchi Tetsuya; Noguchi Shinzaburo
Quantitative assessment of mammographic density and breast cancer risk for Japanese women.
Breast (Edinburgh, Scotland) 2008;17(1):27-35.
2007: Naoi Yasuto; Miyoshi Yasuo; Taguchi Tetsuya; Kim Seung Jin; Arai Takashi; Tamaki Yasuhiro; Noguchi Shinzaburo
Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer.
Breast cancer research and treatment 2007;106(1):11-7.
2007: Takahashi Yuri; Miyoshi Yasuo; Morimoto Koji; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.
Journal of cancer research and clinical oncology 2007;133(8):501-9.
2007: Taguchi Tetsuya
[Prevention of hereditary breast cancer]
Nippon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 6():610-4.
2007: Takahata Chie; Miyoshi Yasuo; Irahara Natsumi; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells.
Cancer letters 2007;250(2):229-36.
2007: Maruyama Naomi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Monden Morito; Noguchi Shinzaburo
Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):408-14.
2007: Yano Kenji; Hosokawa Ko; Masuoka Takeshi; Matsuda Ken; Takada Akiyoshi; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Options for immediate breast reconstruction following skin-sparing mastectomy.
Breast cancer (Tokyo, Japan) 2007;14(4):406-13.
2006: Arai Takashi; Miyoshi Yasuo; Kim Seung Jin; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers.
Breast cancer research and treatment 2006;100(2):169-76.
2006: Irahara Natsumi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.
Cancer letters 2006;243(1):23-31.
2006: Miyoshi Yasuo; Nakayama Satoshi; Torikoshi Yasuhiro; Tanaka Satoshi; Ishihara Hideki; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
Cancer science 2006;97(6):523-9.
2006: Taguchi Tetsuya; Noguchi Shinzaburo
[Clinical applications of GnRHa in breast cancer]
Nippon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 4():85-9.
2006: Morita Satoshi; Oka Yoshihiro; Tsuboi Akihiro; Kawakami Manabu; Maruno Motohiko; Izumoto Shuichi; Osaki Tadashi; Taguchi Tetsuya; Ueda Takafumi; Myoui Akira; Nishida Sumiyuki; Shirakata Toshiaki; Ohno Satoshi; Oji Yusuke; Aozasa Katsuyuki; Hatazawa Jun; Udaka Keiko; Yoshikawa Hideki; Yoshimine Toshiki; Noguchi Shinzaburo; Kawase Ichiro; Nakatsuka Shin-ichi; Sugiyama Haruo; Sakamoto Junichi
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data.
Japanese journal of clinical oncology 2006;36(4):231-6.
2006: Irahara Natsumi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer.
International journal of cancer. Journal international du cancer 2006;118(8):1915-21.
2006: Akazawa Kenji; Tamaki Yasuhiro; Taguchi Tetsuya; Tanji Yoshio; Miyoshi Yasuo; Kim Seung Jin; Ueda Satsuki; Yanagisawa Tetsu; Sato Yoshinobu; Tamura Shinichi; Noguchi Shinzaburo
Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
The breast journal 2006;12(2):130-7.
2006: Miyoshi Yasuo; Funahashi Tohru; Tanaka Sachiyo; Taguchi Tetsuya; Tamaki Yasuhiro; Shimomura Iichiro; Noguchi Shinzaburo
High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels.
International journal of cancer. Journal international du cancer 2006;118(6):1414-9.
2005: Kim Seung Jin; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Nakamura Hajime; Yodoi Junji; Kato Kikuya; Noguchi Shinzaburo
High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8425-30.
2005: Kim Seung Jin; Taguchi Tetsuya; Miyoshi Yasuo; Tanji Yoshio; Tamaki Yasuhiro; Noguchi Shinzaburo
[The feasibility of FEC (75) as adjuvant chemotherapy for Japanese breast cancer patients]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(12):1919-23.
2005: Takahashi Yuri; Miyoshi Yasuo; Takahata Chie; Irahara Natsumi; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(4):1380-5.
2005: Inoue Tomoo; Tamaki Yasuhiro; Hamada Seiki; Yamamoto Shuji; Sato Yoshinobu; Tamura Shinichi; Kim Seung Jin; Tanji Yoshio; Miyoshi Yasuo; Taguchi Tetsuya; Noguchi Shinzaburo
Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patients.
Breast cancer research and treatment 2005;89(2):119-25.
2005: Irahara Natsumi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo; Harada Nobuhiro
Possible involvement of aromatase overexpression induced by cyclo-oxygenase-2 in the pathogenesis of idiopathic gynecomastia.
Endocrine research 2005;31(3):219-27.
2005: Taniguchi Kazuya; Takano Toru; Miyauchi Akira; Koizumi Kyoko; Ito Yasuhiro; Takamura Yuuki; Ishitobi Makoto; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Kato Kikuya; Noguchi Shinzaburo
Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction.
Oncology 2005;69(5):428-35.
2005: Inoue Tomoo; Tamaki Yasuhiro; Sato Yoshinobu; Nakamoto Masahiko; Tamura Shinichi; Tanji Yoshio; Taguchi Tetsuya; Noguchi Shinzaburo
Three-dimensional ultrasound imaging of breast cancer by a real-time intraoperative navigation system.
Breast cancer (Tokyo, Japan) 2005;12(2):122-9.
2005: Miyoshi Yasuo; Taguchi Tetsuya; Kim Seung Jin; Tamaki Yasuhiro; Noguchi Shinzaburo
Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers.
Breast cancer (Tokyo, Japan) 2005;12(1):11-5.
2004: Miyoshi Yasuo; Kim Seung Jin; Akazawa Kenji; Kamigaki Shunji; Ueda Satsuki; Yanagisawa Tetsu; Inoue Tomoo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Down-regulation of intratumoral aromatase messenger RNA levels by docetaxel in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8163-9.
2004: Miyoshi Yasuo; Akazawa Kenji; Kamigaki Shunji; Ueda Satsuki; Yanagisawa Tetsu; Inoue Tomoo; Yamamura Jun; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
Cancer letters 2004;216(1):115-21.
2004: Taguchi Tetsuya; Aihara Tomohiko; Takatsuka Yuichi; Shin Eisei; Motomura Kazuyoshi; Inaji Hideo; Noguchi Shinzaburo;
Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan.
The breast journal 2004;10(6):509-13.
2004: Yamamura Jun; Miyoshi Yasuo; Tamaki Yasuhiro; Taguchi Tetsuya; Iwao Kyoko; Monden Morito; Kato Kikuya; Noguchi Shinzaburo
mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.
Cancer science 2004;95(11):887-92.
2004: Oka Yoshihiro; Tsuboi Akihiro; Taguchi Tetsuya; Osaki Tadashi; Kyo Taiichi; Nakajima Hiroko; Elisseeva Olga A; Oji Yusuke; Kawakami Manabu; Ikegame Kazuhiro; Hosen Naoki; Yoshihara Satoshi; Wu Fei; Fujiki Fumihiro; Murakami Masaki; Masuda Tomoki; Nishida Sumiyuki; Shirakata Toshiaki; Nakatsuka Shin-Ichi; Sasaki Ayako; Udaka Keiko; Dohy Hiroo; Aozasa Katsuyuki; Noguchi Shinzaburo; Kawase Ichiro; Sugiyama Haruo
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(38):13885-90.
2004: Noma Chikako; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Cancer letters 2004;210(2):197-203.
2004: Shimazu Kenzo; Tamaki Yasuhiro; Taguchi Tetsuya; Akazawa Kenji; Inoue Tomoo; Noguchi Shinzaburo
Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Cancer 2004;100(12):2555-61.
2004: Inoue Tomoo; Yutani Kenji; Taguchi Tetsuya; Tamaki Yasuhiro; Shiba Eiichi; Noguchi Shinzaburo
Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Journal of cancer research and clinical oncology 2004;130(5):273-8.
2003: Miyoshi Yasuo; Funahashi Tohru; Kihara Shinji; Taguchi Tetsuya; Tamaki Yasuhiro; Matsuzawa Yuji; Noguchi Shinzaburo
Association of serum adiponectin levels with breast cancer risk.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5699-704.
2003: Miyoshi Y; Ando A; Hasegawa S; Ishitobi M; Yamamura J; Irahara N; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.
European journal of cancer (Oxford, England : 1990) 2003;39(17):2531-7.
2003: Hasegawa Seiichi; Miyoshi Yasuo; Egawa Chiyomi; Ishitobi Makoto; Taguchi Tetsuya; Tamaki Yasuhiro; Monden Morito; Noguchi Shinzaburo
Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2992-7.
2003: Miyoshi Yasuo; Ando Akiko; Hasegawa Seiichi; Ishitobi Makoto; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2288-93.
2003: Miyoshi Yasuo; Tanji Yoshio; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2229-33.
2003: Miyoshi Yasuo; Ando Akiko; Ooka Masaru; Shiba Eiichi; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue.
Cancer letters 2003;195(1):81-6.
2003: Tamaki Yasuhiro; Miyoshi Yasuo; Kim Seung Jin; Tanji Yoshio; Taguchi Tetsuya; Noguchi Shinzaburo
Aromatase inhibitors for treatment of postmenopausal patients with breast cancer.
Expert review of anticancer therapy 2003;3(2):193-201.
2003: Shimazu Kenzo; Tamaki Yasuhiro; Taguchi Tetsuya; Motomura Kazuyoshi; Inaji Hideo; Koyama Hiroki; Kasugai Tsutomu; Wada Akira; Noguchi Shinzaburo
Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
Annals of surgery 2003;237(3):390-8.
2003: Egawa Chiyomi; Motomura Kazuyoshi; Miyoshi Yasuo; Takamura Yuuki; Taguchi Tetsuya; Tamaki Yasuhiro; Inaji Hideo; Koyama Hiroki; Noguchi Shinzaburo
Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers.
Breast cancer research and treatment 2003;78(1):45-50.
2003: Naoi Yasuto; Tamaki Yasuhiro; Ooka Masaru; Tsukamoto Fumine; Miyoshi Yasuo; Tanji Yoshiro; Taguchi Tetsuya; Noguchi Shinzaburo
[A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine]
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(1):145-9.
2003: Yano Kenji; Hosokawa Ko; Nakai Kunihiro; Kubo Tateki; Hattori Ryo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Skin-sparing mastectomy and immediate reconstruction with a deep inferior epigastric perforator flap.
Breast cancer (Tokyo, Japan) 2003;10(3):275-80.
2003: Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Current status of endocrine therapy for breast cancer.
Breast cancer (Tokyo, Japan) 2003;10(2):105-11.
2002: Yoneda Kohri; Tanji Yoshio; Ikeda Noriko; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
Cancer letters 2002;186(2):223-30.
2002: Miyoshi Yasuo; Ando Akiko; Egawa Chiyomi; Taguchi Tetsuya; Tamaki Yasuhiro; Tamaki Hiroya; Sugiyama Haruo; Noguchi Shinzaburo
High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1167-71.
2002: Egawa Chiyomi; Miyoshi Yasuo; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.
International journal of cancer. Journal international du cancer 2002;98(6):879-82.
2002: Takamura Yuuki; Kobayashi Hisayuki; Taguchi Tetsuya; Motomura Kazuyoshi; Inaji Hideo; Noguchi Shinzaburo
Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers.
International journal of cancer. Journal international du cancer 2002;98(3):450-5.
2002: Shimazu Kenzo; Tamaki Yasuhiro; Taguchi Tetsuya; Takamura Yuuki; Noguchi Shinzaburo
Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer.
Surgery 2002;131(3):277-86.
2002: Kim Seung Jin; Shiba Eiichi; Taguchi Tetsuya; Tsukamoto Fumine; Miyoshi Yasuo; Tanji Yoshio; Takai Shin-ichiro; Noguchi Shinzaburo
uPA receptor expression in benign and malignant thyroid tumors.
Anticancer research 2002;22(1A):387-93.
2002: Miyoshi Yasuo; Ando Akiko; Takamura Yuuki; Taguchi Tetsuya; Tamaki Yasuhiro; Noguchi Shinzaburo
Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
International journal of cancer. Journal international du cancer 2002;97(1):129-32.
2002: Tamaki Yasuhiro; Tsukamoto Fumine; Miyoshi Yasuo; Tanji Yoshiro; Taguchi Tetsuya; Noguchi Shinzaburo
Overview: video-assisted breast surgery.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2002;56 Suppl 1():187s-191s.
2001: Miyoshi Y; Ando A; Shiba E; Taguchi T; Tamaki Y; Noguchi S
Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers.
International journal of cancer. Journal international du cancer 2001;94(5):685-9.
2001: Miyoshi Y; Taguchi T; Gustafsson J A; Noguchi S
Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers.
Japanese journal of cancer research : Gann 2001;92(10):1057-61.
2001: Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Cancer 2001;92(2):232-9.
2001: Egawa C; Miyoshi Y; Takamura Y; Taguchi T; Tamaki Y; Noguchi S
Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer.
International journal of cancer. Journal international du cancer 2001;95(4):255-9.
2001: Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.
Japanese journal of cancer research : Gann 2001;92(6):624-30.
2000: Taguchi T
World summit against cancer for the new millennium: 4th February 2000 charter of Paris against cancer.
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(13):2067-78.
2000: Yoneda K; Shiba E; Watanabe T; Akazawa K; Shimazu K; Takamura Y; Kim S; Tsukamoto F; Tanji Y; Taguchi T; Noguchi S
Laparoscopic adrenalectomy: lateral transabdominal approach vs posterior retroperitoneal approach.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2000;54 Suppl 1():215s-219s.
2000: Shiba E; Watanabe T; Taguchi T; Tsukamoto F; Noguchi S
[Plasma concentrations of toremifene citrate and N-desmethyltoremifene in postmenopausal patients with breast cancer--comparison of 120 mg of toremifene citrate administered once a day and divided into 3 separate doses (t.i.d.)]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(2):245-9.
2000: Shiba E; Akazawa K; Kim S J; Taguchi T; Tsukamoto F; Ogawa H; Furukawa J; Yamamoto H; Noguchi S
High dose chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary lymph nodes.
Breast cancer (Tokyo, Japan) 2000;7(4):302-6.
1999: Taguchi T
[Adjuvant chemotherapy for primary breast cancer--review of 1998 St. Gallen's conference]
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(9):1227-41.
1999: Taguchi T; Tsukamoto F; Watanabe T; Yoneda K; Takamura Y; Hojo S; Shiba E; Noguchi S
[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26(8):1163-70.
1999: Taguchi T
[Trends in surgical treatment in various malignancies]
Gan to kagaku ryoho. Cancer & chemotherapy 1999;26 Suppl 1():8-14.
1999: Kim S J; Kimoto Y; Nakamura H; Taguchi T; Tanji Y; Izukura M; Shiba E; Takai S
Ovarian carcinoma with fistula formation to the sigmoid colon and ileum: report of a case.
Surgery today 1999;29(5):449-52.
1998: Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
[Phase I study of raltitrexed (ZD-1694)]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(13):2075-84.
1998: Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Endocrine journal 1998;45(5):637-46.
1998: Taguchi T; Tsukagoshi S; Furue H; Niitani H; Noda K
[Phase I clinical study of oxaliplatin]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(12):1899-907.
1998: Taguchi T; Shiba E; Takai S; Taguchi T
[Characteristics of screening-detected breast cancer and trends in its therapy]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(10):1493-8.
1998: Taguchi T; Shiba E; Takai S; Taguchi T
[Characteristics of screening-detected breast cancer and trends in its therapy]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(10):1493-8.
1998: Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
[Phase I study of orally administered UFT plus l-leucovorin]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(4):531-9.
1998: Taguchi T
[Adjuvant for breast cancer chemo-endocrine therapy]
Gan to kagaku ryoho. Cancer & chemotherapy 1998;25(4):453-67.
1998: Kim S J; Shiba E; Tsukamoto F; Izukura M; Taguchi T; Yoneda K; Tanji Y; Kimoto Y; Takai S I
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer.
Oncology reports 1998;5(2):431-5.
1998: Kimoto Y; Tanji Y; Taguchi T; Sugimoto T; Watanabe T; Tsukamoto F; Kim S; Yoneda K; Takamura Y; Izukura M; Shiba E; Takai S
Antitumor effect of medium-chain triglyceride and its influence on the self-defense system of the body.
Cancer detection and prevention 1998;22(3):219-24.
1997: Taguchi T; Inuyama Y; Kanamaru R; Hasegawa K; Akazawa S; Niitani H; Furue H; Kurihara M; Ota K; Suga S; Ariyoshi Y; Takai S; Shimoyama T; Toge T; Takashima S; Sugimachi K; Hara Y; Fujita H; Kimura K; Saito T; Tsukagoshi S; Nakao I
[Phase I study of S-1. S-1 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(15):2253-64.
1997: Taguchi T
Experience with UFT in Japan.
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 10):30-4.
1997: Taguchi T; Ohta K; Hotta T; Shirakawa S; Masaoka T; Kimura I
[Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(10):1263-71.
1997: Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Ota K; Ariyoshi H; Hattori T; Sugimachi K; Tsukagoshi S
[TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(10):1253-61.
1997: Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
[TUT-7 phase I clinical study. TUT-7 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24(9):1125-33.
1997: Kim S J; Shiba E; Ishii H; Inoue T; Taguchi T; Tanji Y; Kimoto Y; Izukura M; Takai S
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study.
Anticancer research 1997;17(3C):2319-23.
1997: Shiba E; Kim S J; Kambayashi J; Kawamura I; Lacey E; Manda T; Shimomura K; Taguchi T; Takai S
Mechanism of growth inhibition by calpain inhibitor in MCF-7 cells.
Anticancer research 1997;17(3C):1919-23.
1997: Taguchi T
Modulation of 5-FU and its related compounds.
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24 Suppl 1():195-205.
1997: Taguchi T
UFT: biochemical modulation for 5-fluorouracil (5-FU).
Chinese medical journal 1997;110(4):294-6.
1997: Kim S J; Shiba E; Taguchi T; Watanabe T; Tanji Y; Kimoto Y; Izukura M; Takai S I
Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer.
Anticancer research 1997;17(2B):1373-8.
1997: Shiba E; Kim S J; Taguchi T; Izukura M; Kobayashi T; Furukawa J; Yayoi E; Shin E; Takatsuka Y; Koyama H; Takai S
A prospective study on the prognostic significance of urokinase-type plasminogen activator levels in breast cancer tissue.
Journal of cancer research and clinical oncology 1997;123(10):555-9.
1997: Taguchi T
Clinical application of biochemical modulation in cancer chemotherapy: biochemical modulation for 5-FU.
Oncology 1997;54 Suppl 1():12-8.
1996: Taguchi T
[Primary medical therapy (preoperative therapy) in the treatment of operable breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(13):1733-9.
1996: Taguchi T; Furuse K; Fukuoka M; Shimoyama T; Morimoto K; Nakamura T; Furue H; Majima H; Niitani H; Ohta K; Wakui A; Nakao I; Tsukagoshi S
[LY188011 phase I study. Research Group of Gemcitabine (LY188011)]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(8):1011-8.
1996: Kim S; Shiba E; Taguchi T; Kimoto Y; Inoue T; Shimazu K; Takamura Y; Tanji Y; Izukura M; Ogawa H; Sugiyama H; Kubota T; Kimura T; Takai S
[High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(5):635-8.
1996: Shiba E; Kim S; Fujitani M; Kambayashi J I; Kawamura I; Tsujimoto S; Shimomura K; Tanji Y; Taguchi T; Kimoto Y; Izukura M; Takai S I
Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells.
Anticancer research 1996;16(2):773-7.
1996: Dong H D; Kimoto Y; Takai S; Taguchi T
Apoptosis as a mechanism of lectin-dependent monocyte-mediated cytotoxicity.
Immunological investigations 1996;25(1-2):65-78.
1995: Taguchi T
[Side effects of cancer chemotherapy and steps to deal with them]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(14):2017-28.
1995: Taguchi T
Clinical studies of CPT-11 in Japan.
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22 Suppl 3():277-83.
1995: Taguchi T
[Liver tumor targeting of drugs: Spherex, a vascular occlusive agent]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(7):969-76.
1995: Taguchi T; Kosaki G; Onodera T; Endo M; Nakagawara G; Sano K; Kaibara N; Kakegawa T; Nakano S; Kurihara M
[A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (surgery group evaluation)]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(6):753-64.
1995: Taguchi T
[Phase I study]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(5):603-6.
1995: Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
[The clinical phase I study of TNP-351. The TNP-351 Research Committee]
Gan to kagaku ryoho. Cancer & chemotherapy 1995;22(2):259-71.
1994: Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
[An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(14):2453-60.
1994: Taguchi T
[An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(14):2431-7.
1994: Taguchi T; Furue H; Niitani H; Ishitani K; Kanamaru R; Hasegawa K; Ariyoshi Y; Noda K; Furuse K; Fukuoka M
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(12):1997-2005.
1994: Taguchi T; Shiba E; Izukura M; Kimoto Y; Tanji Y; Takai S
[Therapeutic strategy for anaplastic carcinoma and malignant lymphoma of the thyroid]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(10):1593-9.
1994: Taguchi T; Tominaga T; Ogawa M; Ishida T; Morimoto K; Ogawa N
[A late phase II study of CPT-11 (irinotecan) in advanced breast cancer. CPT-11 Study Group on Breast Cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(7):1017-24.
1994: Taguchi T
[Targetting therapy for cancer and drug delivery system]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(6):736-7.
1994: Taguchi T
[Interleukin-2 (IL-2)]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(5):719-24.
1994: Taguchi T
Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres.
Clinical pharmacokinetics 1994;26(4):275-91.
1994: Fujita M; Fujita F; Inaba H; Taguchi T
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(4):517-23.
1994: Taguchi T
[Cytokines]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(2):281-4.
1994: Taguchi T; Yoshida Y; Izuo M; Ishida T; Ogawa M; Nakao I; Tominaga T; Ohkawa T; Oguro M; Yoshida M
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(1):83-90.
1994: Taguchi T
[Present status of home care in oncology]
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21(1):1-4.
1994: Kimoto Y; Tanaka T; Tanji Y; Fujiwara A; Taguchi T
Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies.
Biotherapy (Dordrecht, Netherlands) 1994;8(1):41-50.
1993: Kimoto Y; Tong F Z; Taguchi T
Influence of physiological concentration of progesterone on CD(4+)- and CD(8+)-activated lymphocytes with interleukin 2 and autologous plasma: difference between healthy donors and patients bearing malignant tumors.
Cancer letters 1993;75(3):157-65.
1993: Taguchi T
[Phase I study on infusion of PJ-203 (degradable starch microspheres) into hepatic. PJ-203 Clinical Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(12):1817-25.
1993: Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
[Phase I clinical study of TT-62. Research group of TT-62]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(2):241-6.
1993: Fujita F; Fujita M; Inaba H; Taguchi T
[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(2):223-8.
1993: Taguchi T
[Development of fluorinated pyrimidines in Japan]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(1):10-8.
1992: Dong H D; Kimoto Y; Taguchi T
Pokeweed mitogen induces p55 interleukin-2 receptor expression on human monocytes and its effect on interleukin-2 activated monocyte cytotoxicity.
Immunological investigations 1992;21(7):663-70.
1992: Ohta J; Taguchi T; Furue H; Niitani H; Ota K; Tsukagoshi S; Ariyoshi Y; Ikeda M; Akasaka Y; Suminaga M
[Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(12):2041-55.
1992: Ota J; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Kawahara T; Okumura T; Yamamoto M; Yasutake K
[Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(9):1279-84.
1992: Kimoto Y; Tanaka T; Fujiwara A; Fujita M; Taguchi T
Enhancing effect of pokeweed mitogen on the proliferation and the cytotoxicity of lymphokine-activated killer cells.
Japanese journal of cancer research : Gann 1992;83(6):631-7.
1992: Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1992;19(4):483-8.
1992: Kuroishi T; Tominaga S; Ota J; Horino T; Taguchi T; Ishida T; Yokoe T; Izuo M; Ogita M; Itoh S
The effect of breast self-examination on early detection and survival.
Japanese journal of cancer research : Gann 1992;83(4):344-50.
1991: Horino T; Fujita M; Ueda N; Ota J; Ryo M; Nakano Y; Taguchi T
Efficacy of internal mammary node dissection in the treatment of breast cancer.
Japanese journal of clinical oncology 1991;21(6):422-7.
1991: Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(13):2263-70.
1991: Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
[Antitumor activity of HO-221, a derivative of benzoylphenylurea against human cancer xenografts in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(13):2255-61.
1991: Taguchi T; Tsukagoshi S; Furue H; Niitani H; Ohta K; Ariyoshi H; Hasegawa K; Majima H; Nakao I; Yasutomi M
[Phase I study of CI-898. CI-898 Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1599-612.
1991: Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
[Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1665-75.
1991: Taguchi T; Saito T; Ota J; Nakao I; Ohashi K; Nakamura H; Konno T
[Phase I study of YM881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Research Group for Intra-arterial Infusion Therapy with YM881]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1657-63.
1991: Taguchi T
[DNA topoisomerase inhibitor as chemotherapeutic drug--clinical point of view]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(10):1574-8.
1991: Fujita M; Fujita F; Sakamoto Y; Sugimoto T; Shimozuma K; Taguchi T
[Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(9):1429-37.
1991: Taguchi T
[New interesting chemotherapeutic regimens in advanced gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(6):945-51.
1991: Kuroishi T; Tominaga S; Ota J; Horino T; Taguchi T; Ishida T; Yokoe T; Izuo M; Ogita M; Itoh S
The effect of mass screening for breast cancer: results of a multivariate analysis.
Japanese journal of cancer research : Gann 1991;82(1):27-32.
1991: Taguchi T; Sohmura Y
Clinical studies with TNF.
Biotherapy (Dordrecht, Netherlands) 1991;3(2):177-86.
1990: Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
[Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(11):2191-6.
1990: Fujita M; Sugiyama R; Kumanishi Y; Ota J; Horino T; Nakano Y; Taguchi T
Evaluation of effectiveness of mass screening for colorectal cancer.
World journal of surgery 1990;14(5):648-52; discussion 652-3.
1990: Fujita Y; Ota J; Fujita M; Sugimoto T; Sakamoto Y; Taguchi T
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(8 Pt 2):1653-6.
1990: Taguchi T
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(7):1295-301.
1990: Fujita F; Fujita M; Taguchi T
[Antitumor activities of ME 2303 on human gastrointestinal cancer xenografted to nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(6):1143-50.
1990: Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
[Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(4 Pt 1):627-32.
1990: Sakamoto Y; Fujita M; Ota J; Sugiyama R; Sugimoto T; Taguchi T
[Enhanced effect of intra-arterial adriamycin administration in combination with degradable starch microspheres on an intra-arterial chemotherapy model of nude rats transplanted of human gastric cancer]
Nippon Geka Gakkai zasshi 1990;91(3):326-34.
1990: Kusuyama T; Fujita M; Okuyama Y; Taguchi T
[The persistence and proliferation of tumor-xenografts implanted under the renal capsule of immunocompetent mice, cyclosporin A-treated mice and nude mice]
Nippon Geka Gakkai zasshi 1990;91(3):303-12.
1990: Kusuyama T; Okuyama Y; Fujita M; Taguchi T
[Experimental studies on subrenal capsule assay using cyclosporin A treated mice--the optimal treatment schedules of CsA and anticancer agents (mitomycin C and 5-fluorouracil)]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(2):259-67.
1990: Taguchi T; Wakui A; Hasegawa K; Niitani H; Furue H; Ohta K; Hattori T
[Phase I clinical study of CPT-11. Research group of CPT-11]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(1):115-20.
1989: Ota J; Horino T; Taguchi T; Ishida T; Izuo M; Ogita M; Abe R; Watanabe H; Morimoto T; Itoh S
Mass screening for breast cancer: comparison of the clinical stages and prognosis of breast cancer detected by mass screening and in out-patient clinics.
Japanese journal of cancer research : Gann 1989;80(11):1028-34.
1989: Fujita M; Tanigawa K; Fujita F; Sakamoto Y; Shimozuma K; Kusuyama T; Inaba H; Taguchi T
[Evaluation of predictability of in vitro SDI assay in comparison with in vivo nude mouse assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(10):3435-41.
1989: Taguchi T
[Questionnaire results on implantable catheter systems]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(9):3251-63.
1989: Tsukahara Y; Fujita M; Ohmichi M; Ishii T; Taguchi T
[Selective induction of dog esophageal carcinomas by the restricted oral administration of N-ethyl-N-'-nitro-N-nitrosoguanidine with a projecting spout]
Nippon Geka Gakkai zasshi 1989;90(8):1161-9.
1989: Taguchi T
[Present status of surgical adjuvant chemotherapy of gastric cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(6):2169-72.
1989: Taguchi T
[Overview on the behalf of the Society for Arterial Infusion Chemotherapy Research]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(4 Pt 2-1):919-22.
1989: Fujita F; Fujita M; Taguchi T; Shimozuma K; Sakamoto Y; Kimoto Y; Hirai T
Multifactorial analysis of parameters influencing chemosensitivity of human cancer xenografts in nude mice.
International journal of cancer. Journal international du cancer 1989;43(4):637-44.
1989: Tanji Y; Tanaka T; Kimoto Y; Fujiwara A; Fujita M; Taguchi T
[Mass culture of LAK cells by a hollow-fiber bioreactor system]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(4 Pt 2-3):1888-92.
1989: Fujita M; Nakamura H; Taguchi T
[Recent progress in multidisciplinary treatment of hepatic cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(4 Pt 2-1):1000-7.
1988: Sakamoto Y; Fujita M; Sugiyama R; Ota J; Taguchi T
[Basic studies in intra-arterial chemotherapy with degradable starch microspheres (DSM) on human gastric cancer xenografts in nude rats]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8 Pt 2):2573-7.
1988: Ota J; Fujita M; Nakamura H; Taguchi T
[Hepatic arterial infusion of degradable starch microspheres (DSM) with adriamycin or mitomycin C in liver cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8 Pt 2):2640-5.
1988: Taguchi T; Horino T; Ota J
[Factors influencing on the prognosis in breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(7):2043-9.
1988: Taguchi T
[Recent advances in L-asparaginase studies]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(5):1815-25.
1988: Kimoto Y; Taguchi T
[Adoptive immunotherapy of malignant disease using LAK cells]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(4 Pt 2-1):788-96.
1988: Taguchi T
[Roferon-A. Canferon-A. Interferon alpha-2A (genetic recombination)]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(1):171-6.
1988: Taguchi T
[Changes in the surgical treatment of breast cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(1):15-9.
1988: Kusuyama T; Fujita M; Sakata A; Taguchi T
[Subrenal capsule assay as a chemosensitivity test (V)--Experimental chemotherapy of cyclosporin A-treated mice and nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(1):79-89.
1988: Taguchi T
Phase I study of recombinant human tumor necrosis factor (rHu-TNF:PT-050).
Cancer detection and prevention 1988;12(1-6):561-72.
1988: Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y
Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
Cancer detection and prevention 1988;12(1-6):105-14.
1987: Taguchi T; Kimoto Y; Tanji Y; Abe S; Nakano K; Sohmura Y
Augmentation of cytotoxic activity of recombinant human tumor necrosis factor (rHu-TNF) by recombinant human interferon-gamma (rHu-IFN-gamma).
Journal of biological response modifiers 1987;6(6):599-609.
1987: Kusuyama T; Fujita M; Shimozuma K; Taguchi T
[Subrenal capsule (SRC) assay as a chemosensitivity test (IV)--Evaluation of the SRC assay method as a system for growing implanted tumor-xenografts]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(11):3105-13.
1987: Taguchi T; Ota J; Sumida S; Rii M
[Tumor markers in gastrointestinal cancer and its clinical significance]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(11):3004-9.
1987: Taguchi T
[Clinical results of UFT fine granule therapy by cooperative study. Osaka UFT Granulation Study Group]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(10):2936-43.
1987: Kusuyama T; Fujita M; Origasa H; Shimozuma K; Fujita F; Taguchi T
[Subrenal capsule assay as a chemosensitivity test (III)--Comparison of host reaction, experimental chemotherapy and use of nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(9):2722-9.
1987: Kimoto Y; Fujita M; Taguchi T
Interferon treatment of human stomach and breast carcinoma xenografts in nude mice.
Journal of interferon research 1987;7(4):345-56.
1987: Kusuyama T; Simozuma K; Usugane M; Origasa H; Fujita F; Fujita M; Taguchi T
[Subrenal capsule assay for chemosensitivity test (II)--Sequential changes in the implanted tumor tissue and histological findings]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(7):2352-8.
1987: Kimoto Y; Taguchi T
Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
Biken journal 1987;30(2):29-38.
1987: Kimoto Y; Tanji Y; Tanaka T; Taguchi T
[Adoptive immunotherapy of malignant diseases using normal allogeneic LAK cells]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(6 Pt 1):1884-9.
1987: Fujita F; Fujita M; Yamauchi T; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
[Effects of alternating chemotherapy with 2 non-cross-resistant drug combinations on human alimentary and breast cancer xenografts in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(5 Pt 1):1297-304.
1987: Fujita F; Fujita M; Sakamoto Y; Shimozuma K; Inaba H; Taguchi T
[Combination chemotherapy with 3 or 4 drugs on human breast and gastrointestinal cancer xenografts in nude mice (II)]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(5 Pt 1):1252-9.
1987: Kusuyama T; Fujita M; Shimozuma K; Orikasa H; Usugane M; Taguchi T
[Subrenal capsule assay for chemosensitivity testing]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(4):1143-9.
1987: Kimoto Y; Tanji Y; Tanaka T; Taguchi T
[Adoptive immunotherapy of malignant diseases with LAK cells]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(3 Pt 1):687-92.
1987: Kimoto Y; Tanji Y; Taguchi T
[Blocking factors in human blood which inhibit the cytotoxicity of lymphocytes]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(2):453-8.
1987: Taguchi T
Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc 1987;1():333-49.
1986: Fujita F; Fujita M; Shimozuma K; Hirai T; Taguchi T
[Analyses of factors influencing the chemosensitivity of human tumors xenografted into nude mice (I)]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(11):3221-8.
1986: Fujita F; Fujita M; Shimozuma K; Taguchi T
[Combination chemotherapy of human gastrointestinal and breast cancer xenografts in nude mice with 5'-deoxy-5-fluorouridine and mitomycin C]
Nippon Gan Chiryo Gakkai shi 1986;21(7):1386-96.
1986: Shimozuma K; Fujita M; Sakamoto Y; Fujita F; Kimoto Y; Ishii T; Taguchi T
[Cell proliferation kinetics of human gastric, colorectal, pancreatic and breast cancer cell lines serially transplanted in nude mice]
Nippon Gan Chiryo Gakkai shi 1986;21(6):1249-59.
1986: Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
[Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(4 Pt 2):1227-34.
1985: Fujita F; Fujita M; Kimoto Y; Shimozuma K; Taguchi T
[Chemosensitivity of human gastrointestinal and breast cancer xenografts in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1985;12(2):353-61.
1984: Fujita M; Taguchi T; Nakano Y; Oota J; Kimoto Y; Kumanishi Y; Oomichi M; Usugane M; Ueda N; Tsukahara Y
[Mass screening for colorectal cancer by occult blood testing under restricted diet]
Gan no rinsho. Japan journal of cancer clinics 1984;30(8):925-32.
1982: Saito T; Nakao I; Wakui A; Majima H; Koyama Y; Furue H; Itoh I; Ota K; Taguchi T; Masaoka T; Kimura I
[Phase I study of a new anticancer agent CAM--results of cooperative study]
Gan to kagaku ryoho. Cancer & chemotherapy 1982;9(11):2025-30.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Tetsuya Taguchi

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Tetsuya Taguchi (preview)

All Publications